Multimorbidity in Rheumatoid Arthritis: Literature Review and Future Directions
- 23 November 2023
- journal article
- review article
- Published by Springer Nature in Current Rheumatology Reports
- Vol. 26 (1) , 24-35
Abstract
Purpose of Review To offer a narrative review of literature and an update on rheumatoid arthritis (RA) multimorbidity research over the past five years as well as future directions. Recent Findings Patients with RA experience higher prevalence of multimorbidity (31–86% vs 18–71% in non-RA) and faster accumulation of comorbidities. Patients with multimorbidity have worse outcomes compared to non-RA multimorbid patients and RA without multimorbidity including mortality, cardiac events, and hospitalizations. Comorbid disease clusters often included: cardiopulmonary, cardiometabolic, and depression and pain-related conditions. High-frequency comorbidities included interstitial lung disease, asthma, chronic obstructive pulmonary disease, cardiovascular disease, fibromyalgia, osteoarthritis, and osteoporosis, thyroid disorders, hypertension, and cancer. Furthermore, patients with RA and multimorbidity are paradoxically at increased risk of high RA disease activity but experience a lower likelihood of biologic use and more biologic failures. Summary RA patients experience higher prevalence of multimorbidity and worse outcomes versus non-RA and RA without multimorbidity. Findings call for further studies.Keywords
Funding Information
- NIH-CTSA (1UL1TR002373)
This publication has 39 references indexed in Scilit:
- Starting of biological disease modifying antirheumatic drugs may be postponed in rheumatoid arthritis patients with multimorbidityMedicine, 2018
- Improvement in 5-year mortality in incident rheumatoid arthritis compared with the general population—closing the mortality gapAnnals of the Rheumatic Diseases, 2017
- Mortality in patients with rheumatoid arthritis: a 15-year prospective cohort studyRheumatology International, 2016
- Multimorbidity in rheumatic conditionsWiener klinische Wochenschrift, 2016
- Multiple chronic conditions and healthcare costs among adultsExpert Review of Pharmacoeconomics & Outcomes Research, 2015
- Glucocorticoid-induced osteoporosisRMD Open, 2015
- Mortality in rheumatoid arthritis: the impact of disease activity, treatment with glucocorticoids, TNFα inhibitors and rituximabAnnals of the Rheumatic Diseases, 2015
- A systematic review identifies valid comorbidity indices derived from administrative health dataJournal of Clinical Epidemiology, 2015
- Mortality in established rheumatoid arthritisBest Practice & Research Clinical Rheumatology, 2007
- Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty‐year periodArthritis & Rheumatism, 2002